LAULETTA, GIANFRANCO
 Distribuzione geografica
Continente #
NA - Nord America 4.003
EU - Europa 808
AS - Asia 334
OC - Oceania 1
Totale 5.146
Nazione #
US - Stati Uniti d'America 3.999
SE - Svezia 305
CN - Cina 289
IT - Italia 110
UA - Ucraina 110
DE - Germania 86
FI - Finlandia 71
GB - Regno Unito 64
BE - Belgio 20
VN - Vietnam 20
IN - India 14
FR - Francia 13
IE - Irlanda 12
ES - Italia 5
CA - Canada 4
HK - Hong Kong 3
NL - Olanda 3
PK - Pakistan 3
RU - Federazione Russa 3
BG - Bulgaria 2
IR - Iran 2
AT - Austria 1
AU - Australia 1
HU - Ungheria 1
JP - Giappone 1
KR - Corea 1
MK - Macedonia 1
OM - Oman 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 5.146
Città #
Fairfield 624
Chandler 414
Woodbridge 391
Ashburn 309
Seattle 254
Cambridge 253
Jacksonville 252
Nyköping 238
Houston 231
Wilmington 189
Ann Arbor 174
Roxbury 76
Lawrence 73
Nanjing 72
Beijing 71
New York 63
Des Moines 52
Bari 46
Princeton 46
Inglewood 37
Brooklyn 30
Boardman 28
San Diego 28
Nanchang 24
Hebei 23
Brussels 20
Dong Ket 20
Shenyang 20
London 16
Jiaxing 14
Santa Clara 14
Tianjin 14
Pune 13
Dublin 12
Changsha 10
Grafing 9
Helsinki 8
Jinan 8
Ostuni 8
Guangzhou 7
Dearborn 6
Falls Church 6
Hounslow 6
Paris 6
Rome 6
Tappahannock 5
Marseille 4
Napoli 4
Norwalk 4
San Francisco 4
Taizhou 4
Washington 4
Hefei 3
Kilburn 3
Madrid 3
Modugno 3
Ningbo 3
Noci 3
Rende 3
San Mateo 3
Secaucus 3
Toronto 3
Zhengzhou 3
Ardabil 2
Bologna 2
Boydton 2
Casamassima 2
Elk Grove Village 2
Hangzhou 2
Hong Kong 2
Huzhou 2
Islington 2
Kunming 2
Orense 2
Prescot 2
Putignano 2
Santa Marinella 2
Simi Valley 2
Sofia 2
Taranto 2
Aprilia 1
Baotou 1
Bisceglie 1
Budapest 1
Buffalo 1
Central 1
Chelyabinsk 1
Chicago 1
Den Haag 1
Florence 1
Frankfurt am Main 1
Haikou 1
Indiana 1
Kyiv 1
Lanzhou 1
Los Angeles 1
Ludwigshafen am Rhein 1
Melbourne 1
Milan 1
Modica 1
Totale 4.337
Nome #
PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus-related diseases 134
Hepatitis C virus clearance after direct-acting antivirals in cirrhotic patients by stages of liver impairment: the ITAL-C network study 124
null 122
HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2 116
Clinical Significance of Polymorphisms in Immune Response Genes in Hepatitis C-Related Hepatocellular Carcinoma 115
Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis 113
A different perspective on sofosbuvir-ledipasvir treatment of patients with HCV genotype 1b cirrhosis: The ital-c network study 109
HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study 108
HCV RNA genomic sequences and HCV-E2 glycoprotein in sural nerve biopsies from hcv-infected patients with peripheral neuropathy 106
The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and overt B-cell malignancy 104
SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience 104
Hepatitis C virus infection and mixed cryoglobulinemia 102
CD5/CD20 expression on circulating B cells in HCV-related chronic hepatitis and mixed cryoglobulinemia 102
Transarterial Chemoembolization Plus Sorafenib: A Sequential Therapeutic Scheme for HCV-Related Intermediate-Stage Hepatocellular Carcinoma: A Randomized Clinical Trial. 101
IN SITU SIMULTANEOUS DETECTION OF HEPATITIS C VIRUS RNA AND HEPATITIS C VIRUS-RELATED ANTIGENS IN HEPATOCELLULAR CARCINOMA 100
B CELLS AND HCV: AN INFECTION MODEL OF AUTOIMMUNITY 98
Combined Effects of 2 Interleukin 28B Polymorphisms on the Therapeutic Outcome of Hepatitis C Patients With Circulating Cryoglobulins 98
null 96
Role of the receptor for the globular domain of C1q protein in the pathogenesis of hepatitis C virus-related cryoglobulin vascular damage 94
Detection and quantitation of HCV core protein in single hepatocytes by means of laser capture microdissection and enzyme-linked immunosorbent assay 90
ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib 90
MONOCLONAL ANTIBODY TREATMENT OF MIXED CRYOGLOBULINEMIA RESISTANT TO INTERFERON ALPHA WITH AN ANTI-CD20 87
Direct-acting antiviral agents in the therapy of hepatitis C virus-related mixed cryoglobulinaemia: a single-centre experience 86
B-cell depletion in the treatment of mixed cryoglobulinemia. 82
eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: Final results of the ePHAS study 82
HEPATITIS C VIRUS RNA AND CORE PROTEIN IN KIDNEY GLOMERULAR AND TUBULAR STRUCTURES ISOLATED WITH LASER CAPTURE MICRODISSECTION 82
Role of B-cell attracting chemokine-1 in HCV-related cryoglobulinemic vasculitis 81
Hepatitis C virus infection and mixed cryoglobulinemia: a striking association 81
INCREASED SERUM LEVELS OF THE CHEMOKINE CXCL13 AND UP-REGULATION OF ITS GENE EXPRESSION ARE DISTINCTIVE FEATURES OF HCV-RELATED CRYOGLOBULINEMIA AND CORRELATE WITH ACTIVE CUTANEOUS VASCULITIS 79
null 78
HCV-ASSOCIATED B CELL CLONALITIES IN THE LIVER DO NOT CARRY THE T(14; 18) CHROMOSOMAL TRANSLOCATION 77
Barrett's esophagus and esophageal cancer: An overview. 76
MIXED CRYOGLOBULINEMIA: A MODEL OF VIRUS-RELATED DISEASE IN INTERNAL MEDICINE 75
Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia 71
Intrahepatic B cell clonal expansions and extrahepatic manifestations of chronic HCV infection 69
IMMUNOCHEMICAL AND BIOMOLECULAR STUDIES OF CIRCULATING IMMUNE COMPLEXES ISOLATED FROM PATIENTS WITH ACUTE AND CHRONIC HEPATITIS C VIRUS INFECTION 69
Features of peripheral CD8+CD57+ lymphocytes in patients with autoimmune hemolytic anemia 68
Caratterizzazione di lesione metastatica da carcinoma della mammella con angioecografia. Caso clinico 65
Cryoglobulinemic Vasculitis 65
C4d: a valuable marker of activation of the classical complement pathway in mixed cryoglobulinemia 64
H. pylori infection and gastric cancer: state of the art (review). 63
HCV, Mixed Cryoglobulinemia and Malignant Lymphoproliferation 62
null 61
Potential neutralizing properties of anti-E2 antibodies in HCV-infected patients with lymphoproliferative disorders. 57
Impact of Cryoglobulinemic Syndrome on the Outcome of Chronic Hepatitis C Virus Infection: A 15-Year Prospective Study. 57
Espansione clonale dei linfociti B intraepatici ottenuti da portatori cronici del virus C dell'epatite (HCV) con e senza crioglobulinemia mista 56
Crioglobulinemia mista e infezione da HCV 51
Antikörper gegen hepatitis-C-viren in humanen intravenösen immunoglobulinen. 50
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department 50
VIROLOGICAL ANALYSIS AND PHENOTIPIC CHARACTERIZATION OF PERIPHERAL BLOOD LYMPHOCYTES OF HEPATITIS C VIRUS-INFECTED PATIENTS WITH AND WITHOUT MIXED CRYOGLOBULINEMIA 49
PEGYLATED INTERFERON-A, RIBAVIRIN AND RITUXIMAB COMBINED THERAPY OF HEPATITIS C VIRUS-RELATED MIXED CRYOGLOBULINEMIA: A LONG-TERM STUDY 49
REPLY TO THE LETTER TO THE EDITOR "ANDROGEN DEPRIVATION THERAPY AND RISK OF RHEUMATOID ARTHRITIS IN PATIENTS WITH LOCALIZED PROSTATE CANCER" by YANG et al. 48
null 47
Double filtration plasmapheresis in the treatment of leg ulcers in the course of type IHCV-positive cryoglobulinemia 45
T cell receptor variable beta gene repertoire in liver and peripheral blood lymphocytes of chronically hepatitis C virus-infected patients with and without mixed cryoglobulinaemia 45
Vasculiti primarie sistemiche 43
Espansione clonale dei linfociti B intraepatici ottenuti da portatori cronici del virus C dell'epatite con e senza crioglobulinemia mista 42
In reply. Transarterial chemoembolization plus sorafenib... 41
Basi molecolari dell’associazione tra virus epatite e carcinoma epatocellulare 41
Mieloma multiplo e gammapatie monoclonali: quadri clinici, acquisizioni eziopatogenetiche e progressi terapeutici 40
Cellule ematopoietiche staminali CD34+ e infezione cronica da virus C dell'epatite 40
Trattamento con interferone pegilato-α2b in monoterapia o in associazione con ribavirina e amantadina in pazienti affetti da epatite cronica attiva HCV-correlata non responsivi a interferone non-pegilato 39
Association Between Mixed Cryoglobulinemia, Translocation (14;18), and Persistence of Occult HCV Lymphoid Infection After Treatment 38
La vasculite crioglobulinemica: aspetti clinico-patogenetici 35
Alcolizzazione percutanea del piccolo HCC. Casistica personale 35
Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study 35
Le tecniche di biologia molecolare nello studio dei tessuti fissati e paraffinati 34
Imaging evaluation of pulmonary and non-ischaemic cardiovascular manifestations of covid-19 33
null 32
Natural interferon-Α versus its combination with 6-methyl prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term randomized, controlled study 30
ROLE OF THE RECEPTOR FOR THE GLOBULAR DOMAIN OF C1Q PROTEIN IN THE PATHOGENESIS OF CRYOGLOBULIN-RELATED VASCULAR DAMAGE 30
Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar) 28
Assessment of total Hepatitis C virus (HCV) core protein in HCV-related mixed cryoglobulinemia. 28
Trattamento antivirale in pazienti affetti da epatite cronica attiva HCV correlata e transaminasi normali 27
Immunodetection of hepatitis C virus (HCV)-related antigens in tissues: problems and perspectives 25
Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study 20
Interleukin 28B gene polymorphisms in hepatitis C virus-related cryoglobulinemic vasculitis. 20
Role of the receptor for the globular domain of C1q protein in the pathogenesis of HCV-related cryoglobulin vascular damage 18
Serum IgM in type II mixed cryoglobulinemia recognize HCV E2 peptides 18
Double-filtration plasmapheresis in the treatment of leg ulcers in cryoglobulinemia 18
A Challenging Case of Visceral Leishmaniasis 17
Autoimmune Hepatitis: Factors Involved in Initiation and Methods of Diagnosis and Treatment 15
Hepatitis C virus productive infection in mononuclear cells from patients with cryoglobulinemia 14
Termoablazione a radiofrequenza vs alcolizzazione percutanea nel trattamento del piccolo epatocarcinoma. Studio prospettico, randomizzato 13
Terapia della sindrome crioglobulinemica 10
The wide spectrum of cryoglobulinemic vasculitis and an overview of therapeutic advancements 8
Lung Ultrasound Is Useful for Evaluating Lung Damage in COVID-19 Patients Treated with Bamlanivimab and Etesevimab: A Single-Center Pilot Study 7
P87 MEDIASTINAL SYNDROME REVEALED HEART LOCALIZATION OF A PRIMARY MEDIASTINAL B-CELL LYMPHOMA 2
Hepatitis B virus-infection related cryoglobulinemic vasculitis. Clinical manifestations and the effect of antiviral therapy: A review of the literature 1
COVID-19 vaccination rate and safety profile in a multicentre Italian population affected by mixed cryoglobulinaemic vasculitis 1
Immune disturbance leads to pulmonary embolism in COVID-19 more than classical risk factors: a clinical and histological study 1
Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC) 1
A Novel Automatic Algorithm to Support Lung Ultrasound Non-Expert Physicians in Interstitial Pneumonia Evaluation: A Single-Center Study 1
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity 1
Pulmonary Embolism in COVID-19 Patients Is Not Related to a Deterioration of Tissue Oxygenation 1
Totale 5.336
Categoria #
all - tutte 20.412
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.412


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019434 0 0 0 0 0 0 0 0 0 78 161 195
2019/20201.440 208 77 35 121 165 91 153 145 186 109 107 43
2020/2021974 68 117 64 76 112 54 76 67 86 130 68 56
2021/2022668 48 90 9 24 27 57 28 30 41 53 114 147
2022/20231.097 146 117 78 98 105 168 14 153 169 4 25 20
2023/2024326 33 77 16 25 34 93 20 19 4 5 0 0
Totale 5.336